See more : Sydinvest Tyskland KL (SYITYSKADKK.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Andlauer Healthcare Group Inc. (ANDHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Andlauer Healthcare Group Inc., a leading company in the Integrated Freight & Logistics industry within the Industrials sector.
- LleidaNetworks Serveis Telemàtics, S.A. (LLEIF) Income Statement Analysis – Financial Results
- Winton Land Limited (WIN.NZ) Income Statement Analysis – Financial Results
- Minority Equality Opportunities Acquisition Inc. (MEOAU) Income Statement Analysis – Financial Results
- HELMA Eigenheimbau Aktiengesellschaft (H5E.DE) Income Statement Analysis – Financial Results
- Fukuda Corporation (1899.T) Income Statement Analysis – Financial Results
Andlauer Healthcare Group Inc. (ANDHF)
Industry: Integrated Freight & Logistics
Sector: Industrials
Website: https://www.andlauerhealthcare.com
About Andlauer Healthcare Group Inc.
Andlauer Healthcare Group Inc., a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics. It provides logistics and distribution services, including client and customer integration, transportation and inventory management, distribution and fulfillment, and warehousing solutions; and packaging services, such as co-packing and re-packing, assembly, and custom work services. The company also offers temperature-controlled services; air freight forwarding services; dedicated and last mile delivery services; and ground transportation services, including less-than-truckload, pick-up and delivery, and courier services, as well as carrier options. It provides services to healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. The company was founded in 1991 and is headquartered in Vaughan, Canada. Andlauer Healthcare Group Inc. opeates as a subsidiary of Andlauer Management Group Inc.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 647.95M | 648.42M | 440.12M | 314.34M | 289.99M | 277.01M | 251.03M | 223.59M |
| Cost of Revenue | 500.47M | 489.58M | 329.36M | 234.79M | 221.90M | 214.46M | 196.64M | 172.46M |
| Gross Profit | 147.48M | 158.85M | 110.75M | 79.55M | 68.09M | 62.55M | 54.39M | 51.13M |
| Gross Profit Ratio | 22.76% | 24.50% | 25.16% | 25.31% | 23.48% | 22.58% | 21.67% | 22.87% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 51.43M | 48.50M | 37.05M | 28.61M | 23.09M | 21.68M | 20.39M | 20.69M |
| Other Expenses | 0.00 | -328.00K | 368.00K | -49.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 51.43M | 48.50M | 37.05M | 28.61M | 23.09M | 21.68M | 20.39M | 20.69M |
| Cost & Expenses | 551.90M | 538.08M | 366.41M | 263.40M | 245.00M | 236.14M | 217.04M | 193.16M |
| Interest Income | 3.17M | 599.00K | 198.00K | 285.00K | 1.00M | 1.59M | 2.17M | 2.04M |
| Interest Expense | 8.21M | 6.86M | 6.22M | 4.60M | 3.50M | 3.05M | 3.14M | 3.03M |
| Depreciation & Amortization | 37.70M | 64.45M | 42.72M | 28.02M | 25.71M | 23.49M | 23.63M | 21.97M |
| EBITDA | 133.75M | 175.07M | 116.42M | 79.20M | 70.70M | 64.36M | 57.62M | 52.40M |
| EBITDA Ratio | 20.64% | 26.96% | 26.45% | 25.12% | 24.38% | 23.23% | 22.95% | 23.44% |
| Operating Income | 96.05M | 110.35M | 73.70M | 50.94M | 44.99M | 40.87M | 33.99M | 30.44M |
| Operating Income Ratio | 14.82% | 17.02% | 16.75% | 16.21% | 15.52% | 14.75% | 13.54% | 13.61% |
| Total Other Income/Expenses | -5.45M | -6.59M | 32.27M | -4.36M | -2.64M | -2.15M | -2.29M | -2.52M |
| Income Before Tax | 90.61M | 103.76M | 105.97M | 46.58M | 42.35M | 38.72M | 31.70M | 27.92M |
| Income Before Tax Ratio | 13.98% | 16.00% | 24.08% | 14.82% | 14.60% | 13.98% | 12.63% | 12.49% |
| Income Tax Expense | 24.47M | 27.48M | 18.49M | 8.87M | 12.00M | 10.53M | 8.52M | 7.44M |
| Net Income | 66.14M | 76.28M | 89.95M | 37.71M | 29.77M | 26.72M | 21.68M | 19.15M |
| Net Income Ratio | 10.21% | 11.76% | 20.44% | 12.00% | 10.27% | 9.65% | 8.64% | 8.56% |
| EPS | 1.55 | 1.82 | 2.30 | 1.00 | 0.79 | 0.69 | 0.56 | 0.49 |
| EPS Diluted | 1.55 | 1.79 | 2.25 | 0.98 | 0.79 | 0.69 | 0.56 | 0.49 |
| Weighted Avg Shares Out | 42.67M | 41.81M | 39.04M | 37.60M | 37.60M | 38.88M | 38.88M | 38.88M |
| Weighted Avg Shares Out (Dil) | 42.54M | 42.67M | 39.99M | 38.48M | 37.77M | 38.88M | 38.88M | 38.88M |
Source: https://incomestatements.info
Category: Stock Reports